Wintz, K.; Post, J.; Langen, K.-J.; Willbold, D.; Willuweit, A.; Kutzsche, J.
Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival. Biomedicines 2023, 11, 995.
https://doi.org/10.3390/biomedicines11040995
AMA Style
Wintz K, Post J, Langen K-J, Willbold D, Willuweit A, Kutzsche J.
Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival. Biomedicines. 2023; 11(4):995.
https://doi.org/10.3390/biomedicines11040995
Chicago/Turabian Style
Wintz, Katharina, Julia Post, Karl-Josef Langen, Dieter Willbold, Antje Willuweit, and Janine Kutzsche.
2023. "Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival" Biomedicines 11, no. 4: 995.
https://doi.org/10.3390/biomedicines11040995
APA Style
Wintz, K., Post, J., Langen, K. -J., Willbold, D., Willuweit, A., & Kutzsche, J.
(2023). Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival. Biomedicines, 11(4), 995.
https://doi.org/10.3390/biomedicines11040995
